Cargando…

Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug

OBJECTIVES: The single- and multiple-dose pharmacokinetics (PK) of tedizolid were examined after oral administration of tedizolid phosphate disodium (TPD), including the effect of food on PK. The relative bioavailability of TPD to the free acid tedizolid phosphate was determined to bridge the result...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flanagan, Shawn D, Bien, Paul A, Muñoz, Kelly A, Minassian, Sonia L, Prokocimer, Philippe G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2013
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238735/ https://www.ncbi.nlm.nih.gov/pubmed/23926058 http://dx.doi.org/10.1002/phar.1337

Ejemplares similares

Single- and Multiple-Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid
por: Flanagan, Shawn, et al.
Publicado: (2014)

Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers
por: Flanagan, Shawn, et al.
Publicado: (2018)

264 Results of the Surveillance of Tedizolid Activity and Resistance (STAR) Program: In Vitro Susceptibility of Gram-Positive Clinical Isolates Collected in 2013 From the United States
por: Bien, Paul, et al.
Publicado: (2014)

Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections
por: Ortiz-Covarrubias, Alejandro, et al.
Publicado: (2016)

Stability of Crushed Tedizolid Phosphate Tablets for Nasogastric Tube Administration
por: Kennedy, Gerard, et al.
Publicado: (2015)

Pharmacokinetics and Pharmacodynamics of Tedizolid
por: Iqbal, Khalid, et al.
Publicado: (2022)

Stability of crushed tedizolid phosphate tablets for nasogastric tube administration
por: Kennedy, G, et al.
Publicado: (2015)

Outpatient treatment of acute bacterial skin and skin structure infections (ABSSSI) with tedizolid phosphate and linezolid in patients in the United States: Subgroup analysis of 2 randomized phase 3 trials
por: De Anda, Carisa, et al.
Publicado: (2017)

262 Effect of NSAID/Corticosteroid Use on the Efficacy of Tedizolid in Acute Bacterial Skin and Skin Structure Infections: Pooled Data From the Phase 3 ESTABLISH-1 and ESTABLISH-2 Studies
por: Sandison, Taylor, et al.
Publicado: (2014)

Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials
por: Moran, Gregory J., et al.
Publicado: (2018)

Tedizolid vs Linezolid for the Treatment of Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients
por: Poon, Yi Kee, et al.
Publicado: (2021)

A Retrospective Study to Compare the Incidence of Hyponatremia after Administration between Linezolid and Tedizolid
por: Shibata, Yuichi, et al.
Publicado: (2023)

Understanding the pharmacokinetics of prodrug and metabolite
por: Cho, Seungil, et al.
Publicado: (2018)

In vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid
por: Zhang, Huiyun, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2021)

Tedizolid Phosphate: a Next-Generation Oxazolidinone
por: Rybak, Jeffrey M., et al.
Publicado: (2015)

Tedizolid: new data and experiences for clinical practice
por: Lletí, Miguel Salavert, et al.
Publicado: (2021)

1096. Linezolid versus Tedizolid for the Treatment of Nontuberculous Mycobacteria in Solid Organ Transplant Recipients: An Assessment of Safety
por: Poon, Yi Kee, et al.
Publicado: (2020)

1083. Clinical Efficacy of Tedizolid for the Treatment of Mycobacterium abscessus complex Infections in Solid Organ Transplant Recipients
por: Poon, Yi Kee, et al.
Publicado: (2020)

Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone
por: Zurenko, Gary, et al.
Publicado: (2014)

A phase 1 study of intravenously administered TR-701 FA in subjects with advanced renal impairment
por: Flanagan, S, et al.
Publicado: (2013)

Characteristics of Tedizolid Non-susceptible Enterococcal Clinical Isolates
por: Dhand, Abhay, et al.
Publicado: (2017)

Effect of the human endotoxin challenge on tedizolid tissue penetration
por: Jorda, Anselm, et al.
Publicado: (2022)

Pharmacokinetics of Nanosomal Form of Levodopa in Intranasal Administration
por: Nedorubov, Andrey Anatolievich, et al.
Publicado: (2019)

Pharmacokinetics and Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users
por: Mickle, Travis C, et al.
Publicado: (2018)

Pharmacokinetics of Stereoisomeric Dipeptide Prodrugs of Acyclovir Following Intravenous and Oral Administrations in Rats: A Study Involving In vivo Corneal Uptake of Acyclovir Following Oral Dosing
por: Talluri, Ravi S., et al.
Publicado: (2009)

Tedizolid clearance by in vitro continuous renal replacement therapy model
por: Lewis, SJ, et al.
Publicado: (2015)

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
por: Binyamin, Dana, et al.
Publicado: (2018)

Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
por: Ruth, Mike Marvin, et al.
Publicado: (2020)

Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection
por: Shaw, Timothy David, et al.
Publicado: (2021)

Development and Evaluation of Chitosan Nanoparticles for Ocular Delivery of Tedizolid Phosphate
por: Kalam, Mohd Abul, et al.
Publicado: (2022)

Safety and tolerability of tedizolid as oral treatment for bone and joint infections
por: Miller, Loren G., et al.
Publicado: (2023)

Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections
por: Li, Dan, et al.
Publicado: (2021)

1286. Pharmacokinetics, Excretion, and Mass Balance of [(14)C]-Rezafungin Following Intravenous (IV) Administration in Healthy Adults
por: Ong, Voon, et al.
Publicado: (2020)

Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections
por: Urbina, Olatz, et al.
Publicado: (2013)

306. Safety and Tolerability of Tedizolid as Oral Treatment for Bone and Joint Infections
por: Launer, Bryn, et al.
Publicado: (2018)

Tedizolid-Cyclodextrin System as Delayed-Release Drug Delivery with Antibacterial Activity
por: Paczkowska-Walendowska, Magdalena, et al.
Publicado: (2020)

1289. Assessing the Safety and Efficacy with Prolonged Use of Tedizolid in Orthopedic Patients
por: Garza, Daniel E, et al.
Publicado: (2023)

Synthesis, Biological Evaluation, and Pharmacokinetic Study of Novel Liguzinediol Prodrugs
por: Liu, Zheng, et al.
Publicado: (2013)

Safety, pharmacokinetics, and pharmacodynamics of Gln‐1062, a prodrug of galantamine
por: Bakker, Charlotte, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9jjk9tl707hl4ds0v36s1ubqkk